Browse 122 retinitis pigmentosa clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Retinitis pigmentosa usually begins with trouble seeing at night and slowly narrows side vision, and more than 100 genes have been linked to it. The eye was the site of a medical first: in 2017 the FDA approved its first gene therapy for an inherited disease, for vision loss caused by one of those genes. Most people with retinitis pigmentosa have a different gene change and still no approved treatment. Gene therapies, cell therapies, and treatments that work regardless of the gene are now in trials, and genetic testing is the first step toward them.